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sible for 1.5 million emergency department visits, 726,000 hospitalizations, and approximately
119,000 deaths in 2000.
The aim of the work: To identify some factors that may inﬂuence outcome in patients with
COPD exacerbations admitted to ICU to enable clinicians for better management in the future.
Patient and methods: This study was carried out at the respiratory ICU of Chest Department
Zagazig University Hospitals during the period from October 2008 to May 2010. One hundred
COPD patients, admitted to ICU due to acute exacerbations of their illness, 42 with moderate exac-
erbations and 58 with sever exacerbations were included. Patients of the current study were classi-
ﬁed according to initial planning of management into 3 groups.
Group I included 20 patients indicated conservative treatment only. Group II included 20 patients
indicated non-invasive ventilation (NIV) plus conservative treatment. Group III included 60
patients for whom invasive mechanical ventilation (IMV) was indicated plus conservative treat-
ment. Assessment of the ﬁnal outcome regarding: (a) death, (b) improvement and discharge without23595477.
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230 M.A. Mohamed et al.readmission within 1 month of discharge, (c) improvement and discharge with readmission within
1 month.
Results: There was a signiﬁcant difference among the three studied groups when compared
regarding the duration of exacerbation, Glasgow coma scale, pulse rate, RR, level of total plasma
proteins and serum albumin with worst parameters being in patients who indicated IMV. There was
also a signiﬁcant difference among the three studied groups on admission as regards pH, PaO2,
PaCO2, HCO3, SO2 and serum potassium level with worst parameters in patients indicated invasive
ventilation. The best outcome was in group I as 14 patients (70%) discharged without relapse within
1 month and there were no deaths.
Conclusion: The overall ICU mortality and readmission rates were highly found in patients who
indicated IMV. On the other hand the overall discharge rate without the need for readmission was
noted to a great extent in patients who improved on conservative treatment only.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.Introduction
Anacute exacerbation of chronic obstructive pulmonary disease
(AECOPD) was responsible for 1.5 million emergency depart-
ment visits, 726,000 hospitalizations, and approximately
119,000 deaths in 2000. The annual hospitalization rate for
COPD in the United States increased from 9.7 to 24.5 per
10,000 populations between 1988 and 1998, and the vast major-
ity of these were due to AECOPD. The average patient with
COPD experiences two episodes of AECOPD per year and
10%of these episodes require hospitalization.The averagedura-
tion of an episode is 7 days, although it may take several months
for the patient to return to baseline functional status [1,2]. The
aim of the work was to identify some factors that may inﬂuence
outcome in patients with COPD exacerbations admitted to ICU
to enable clinicians for better management in the future.
Patients and methods
This study was carried out at the respiratory ICU of Chest
Department Zagazig University Hospitals during the period
from October 2008 to May 2010. One hundred COPD
patients, admitted to ICU due to acute exacerbation of their
illness, 42 with moderate exacerbations and 58 with sever exac-
erbations were included. Their ages ranged from 50 to 81 years
with mean ± SD= 64.68 ± 6.87 years. COPD was diagnosed
and its severity was determined according to GOLD 2008 [3].
Patients of the current study were classiﬁed according to initial
planning of management into 3 groups.
Group I: Included 20 patients indicated conservative treat-
ment only.
Group II: Included 20 patients indicated non-invasive venti-
lation (NIV) plus conservative treatment.
Group III: Included 60 patients for whom invasive mechan-
ical ventilation (IMV) was indicated plus conservative
treatment.
Methods
On admission to ICU the followings were carried out for all
patients:
(1) Full medical history from the patient (if possible) or his
or her relatives.(2) Full clinical examination: (general & local).
(3) Plain chest and heart X-ray (postero-anterior or antero-
posterior) according to the circumstances.
(4) Arterial blood gas analysis by means of a blood gas
analyzer.
(5) Laboratory investigations:
a- Serum electrolytes (Na, K, Cl, Mg, Ca).
b- Complete blood count (CBC).
c- Routine liver and kidney function tests.
(6) Electrocardiography (ECG).
(7) Assessment of Glasgow coma scale (GCS).
(8) CT pulmonary angiography and Color Doppler Ultra-
Sonography of blood vessels of both lower limps if pul-
monary embolism is suspected.
(9) Management and follow up:
I- Conservative management
A treatment strategy was individualized for each patient
according to the protocols adopted by Chest Department
Zagazig University Hospitals. The decision to initiate ventila-
tory support was taken by the treating physician if the
response to conservative medical treatment was poor as evi-
denced by the deterioration of arterial blood gas levels as well
as pH values and clinical signs.
I- Ventilatory support
(A) Noninvasive ventilation: (NIV): Whenever required, NIV
was used for 20 patients according to GOLD 2007 [4]. Eight
patients failed to respond to NIV and were intubated and
mechanically ventilated.
(B) Invasive mechanical ventilation (IMV): 60 patients
were indicated for invasive mechanical ventilation from the
start and 8 patients after failure of NIV.
Indications for Invasive Mechanical Ventilation according
to GOLD 2007 [4].
Weaning from IMV
The weaning process started when patients showed an
improvement or resolution of the underlying cause of acute
respiratory failure and other criteria according to Raoof
(2003) [5].
(11) Estimation of BODE index before discharge
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(B) Body mass index; (O) airﬂow obstruction measured by
the forced expiratory volume in the ﬁrst second of expiration
(D) dyspnea measured by the modiﬁed Medical Research
Council (MMRC) scale; and (E) exercise capacity measured
by the 6-min walk distance (6MWD). Each component is
graded and a score out of 10 is obtained, with higher scores
indicating greater risk. The BODE index reﬂects the impact
of both pulmonary and extra pulmonary factors on prognosis
and survival in COPD patients [6].
(12) Assessment of the ﬁnal outcome regarding
(a) Death.
(b) Improvement and discharge without readmission within
1 month of discharge.
(c) Improvement and discharge with readmission within
1 month.
Statistical analysis
Data were entered checked and analyzed using Epi-Info ver-
sion 6 and SPSS for Windows version 11.0 (SPSS, Chicago,
IL, USA).Results
Table 1 shows a signiﬁcant difference among the three studied
groups when compared regarding the duration of exacerba-
tion, Glasgow coma scale, pulse rate, RR, level of total plasma
proteins and serum albumin with worst parameters being in
patients who received IMV.
Table 2 shows a signiﬁcant difference among the three stud-
ied groups as regards pH, PaO2, PaCO2, HCO3, SO2 and ser-
um potassium level with worst parameters in patients receiving
invasive ventilation with no signiﬁcant difference as regards
serum levels of other electrolytes.
Table 3 shows that success in invasive mechanical ventila-
tion was higher than that in noninvasive mechanical ventilationTable 1 Comparison among studied patient groups as regards clin
Clinical data on admission Patients under
conservative
management
(group I)
(total n= 20)
Patients with
noninvasive
ventilation
(group II)
(total n= 20)
Duration of COPD (years) 14.6 ± 3.73 15 ± 5.96
Duration of exacerbation (days) 4.6 ± 2.25 5.9 ± 2.12
GCS 13.8 ± 1.10 12.8 ± 1.57
Pulse (beats/min) 103.5 ± 8.1 116.8 ± 9.5
MBP (mmHg) 96.7 ± 12.0 99.2 ± 11.9
Respiratory rate (breaths/minute) 24.2 ± 3.7 33.1 ± 4.5
Ht% 42.6 ± 5.8 42.4 ± 5.7
Total plasma proteins (g/dl) 7.04 ± 0.40 6.5 ± 0.489
Serum albumin(g/dl) 3.69 ± 0.36 3.22 ± 0.456
Serum creatinine (mg/dl) 1.12 ± 0.39 1.16 ± 0.31
Ht: hematocrit value; MBP: mean arterial blood pressure; GCS: Glasgow
P1 probability of difference between patients with conservative managem
P2 probability of difference between patients with conservative managem
P3 probability of difference between patients with noninvasive ventilatiorepresented by 80% in invasive mechanical ventilation versus
60% in noninvasive mechanical ventilation.
Table 4 shows that the best outcome was in group I as 14
patients (70%) discharged without relapse within 1 month
and there were no deaths, while the opposite was in group
III as there were the worst outcome as 12 patients (20%) died,
38 patients (63.3%) relapsed within 1 month after discharge
and 10 patients (16.7%) cured without relapse within 1 month
and the difference between the three groups was statistically
signiﬁcant.
Table 5 shows a signiﬁcant difference among the three stud-
ied groups as regards body mass index, FEVl, 6 min walk test,
MMRC dyspnea scale and total BODE index with worst
parameters in patients receiving invasive ventilation.
Table 6 shows a signiﬁcant difference among discharged pa-
tients without relapse within 1 month and readmitted patients
within 1 month after discharge as regards body mass index,
FEVl, 6 MWT, MMRC dyspnea scale and total BODE index
with worst parameters in relapsed patients.
Discussion
It is obvious that COPD puts an enormous economic burden
on the society. It is estimated that almost 35–45% of the total
per capita health-care costs for COPD attributed to exacerba-
tions alone. Severe exacerbations requiring hospitalizations are
responsible for a large share of these costs [7]. Moreover, more
than half of the patients discharged with AE-COPD often re-
quire re-admission in the subsequent months. Thus, the eco-
nomic and social burden of AE-COPD is extremely high [8].
As the ICU admitted COPD patients due to acute exacer-
bations are increasing; it was a must to study characteristics
of such patients that inﬂuence outcome of these patients. De-
spite being the only major disease showing an increasing rate,
factors that determine outcomes of patients with COPD exac-
erbations are not yet precisely understood. Identiﬁcation of the
factors that may inﬂuence survival in patients with COPD may
enable clinicians to better assess life expectancy. This is extre-
mely important, in that it may help offset the social and eco-
nomic burden of COPD through the implementation ofical and laboratory data on admission.
Patients with
invasive
ventilation
(group III)
(total n= 60)
P P1 P2 P3
14.57 ± 5.14 0.945
7.55 ± 2.16 0.000 >0.05 <0.001 0.001
10.73 ± 1.49 0.000 <0.05 <0.001 <0.001
117.1 ± 15.1 <0.001 <0.001 0.001 >0.05
97.3 ± 13.3 0.740
35.7 ± 2.5 0.001 <0.001 <0.001 >0.05
43.0 ± 7 0.93
6.18 ± 0.678 0.000 0.001 <0.001 >0.05
2.64 ± 0.699 0.000 <0.001 <0.001 <0.001
1.40 ± 0.76 0.14
coma scale.
ent and patients with noninvasive ventilation.
ent and patients with invasive mechanical ventilation.
n and patients with invasive mechanical ventilation.
Table 3 Outcome of ventilatory support in group II and
group III.
Group II [NIV]
(n= 20)
Group III [IMV]
(n= 60)
X2 P
Outcome of ventilatory support
Success 12(60%) 48(80%) 3.2 0.07
Failure 8(40%) 12(20%)
Table 2 Comparison among studied patient groups according to arterial blood gases and serum electrolyte levels on admission.
Patients under
conservative
management
(group I)
(total n= 20)
Patients with
noninvasive
ventilation
(group II)
(total n= 20)
Patients with
invasive
ventilation
(group III)
(total n= 60)
P P1 P2 P3
pH 7.30 ± 0.02 7.21 ± 0.05 7.18 ± 0.03 0.000 <0.001 <0.001 <0.001
PaO2 (mmHg) 58 ± 5.35 52.77 ± 13.8 49.7 ± 7.19 0.001 >0.05 O.001 >0.05
PaCO2 (mmHg) 79.35 ± 10.26 9o.65 ± 16.08 98.5 ± 9.7 0.000 <0.001 <0.001 <0.001
HCO3 (meq/L) 35.35 ± 2.86 38.42 ± 7.36 40.99 ± 5.81 0.001 >0.05 <0.001 >0.05
SO2 (%) 81.40 ± 4.66 78.98 ± 6.08 75.21 ± 8.42 0.004 >0.05 <0.001 >0.05
Na (mEq/L) 136.3 ± 5.17 133.5 ± 5.82 133.03 ± 5.41 0.071
K (mEq/L) 4.02 ± 0.59 3.61 ± 0.38 3.55 ± 0.45 0.001 <0.05 <0.001 >0.05
Cl (mEq/L) 95.40 ± 5.27 97.75 ± 7.23 94.U6.63 0.098
Ca (mg/dL) 10.11 ± 0.63 10.34 ± 0.69 9.88 ± 0.99 0.123
Mg (mg/dL) 2.08 ± 0.18 2.11 ± 0.42 1.98 ± 0.30 0.208
P1 probability of difference between patients with conservative management and patients with noninvasive ventilation.
P2 probability of difference between patients with conservative management and patients with invasive mechanical ventilation.
P3 probability of difference between patients with noninvasive ventilation and patients with invasive mechanical ventilation.
Table 5 Comparison among studied patients groups according to B
Patients under
conservative
management
(group I)
(total n= 20)
Patients wit
noninvasive
ventilation
(group II)
(total n= 1
Body mass index (mean ± SD) 24.50 ± 2.11 23.13 ± 1.8
FEV1 (mean ± SD) 58.70 ± 9.57 58.38 ± 7.9
6 Minute walk test (mean ± SD) 205 ± 78.8 198.7 ± 106
MMRC dyspnea scale (mean ± SD) 2.5 ± 0.69 2.5 ± 1.1
Total BODE score (mean ± SD) 4.2 ± 2.5 4.3 ± 2.5
P1 probability of difference between patients with conservative managem
P2 probability of difference between patients with conservative managem
P3 probability of difference between patients with noninvasive ventilatio
Table 4 Comparison among studied patient groups according to ﬁ
Final outcome Pa
co
m
(g
(to
Improvement without readmission within 1 month after discharge
(n= 36)
14
Improvement with readmission within 1 month after discharge
(n= 50)
6(
Death (n= 14) 0(
232 M.A. Mohamed et al.more individualized and effective treatment strategies, as well
as better mobilizing healthcare resources [9].
Shorter durations of exacerbations were a predictor of
success of conservative treatment while longer durations of
exacerbations were a predictor of need for ventilatory support
(either non-invasive or invasive) (Table 1). This could be
attributed to the fact that failure of exacerbation to respond
to initial medical management at home, ED or hospital ward
consumes time, lengthens the duration of exacerbation,ODE index before discharge.
h
8)
Patients with
invasive
ventilation
(group III)
(total n= 48)
P P1 P2 P3
2 22.92 ± 2.61 0.04 >0.05 <0.05 >0.05
1 45.80 ± 10.80 0.000 >0.05 <0.001 <0.001
.7 133.6 ± 72.8 0.001 >0.05 <0.001 <0.001
5 3.32 ± 0.74 0.000 >0.05 <0.001 <0.001
6.8 ± 2.3 0.001 >0.05 <0.05 <0.05
ent and patients with noninvasive ventilation.
ent and patients with invasive mechanical ventilation.
n and patients with invasive mechanical ventilation.
nal outcome.
tients under
nservative
anagement
roup I)
tal n= 20)
Patients with
noninvasive
ventilation
(group II)
(total n= 20)
Patients with
invasive
ventilation
(group III)
(total n= 60)
X2 P
(70%) 12(60%) 10(16.7%) 24.7 0.000
30%) 6(30%) 38(63.3%) 10.6 0.004
0%) 2(10%) 12(20%) 5.32 0.07
Table 6 Comparison between improved patients without readmission within 1 month after discharge and improved patients with
readmission within 1 month after discharge as regards BODE index.
Improvement without
readmission within 1 month
after discharge (n= 36)
Improvement with readmission
within 1 month after
discharge (n= 50)
t P
Body mass index (mean ± SD) 25.0 ± 1.8 22.1 ± 2.1 6.61 0.000
FEV1
(mean ± SD)
63.3 ± 3.8 42.3 ± 6.5 17.2 0.000
6MWT
(mean ± SD)
245.0 ± 63.3 102.8 ± 41.5 12.5 0.000
MMRC dyspnea scale (mean ± SD) 2.11 ± 0.57 3.6 ± 0.49 12.8 0.000
Total BODE index (mean ± SD) 2.83 ± 0.84 7.88 ± 1.15 22.2 0.000
Intensive care unit of Chest Department Zagazig University Hospitals’ 233deteriorates the condition and predicts poor outcome. Total
plasma protein levels and serum albumin concentrations reﬂect
the metabolic and nutritional status of the patients. Low serum
albumin is a marker of an underlying disease and not a cause
of it. Albumin levels have long been used as a measure of
health and disease reported to be a powerful indicator of an in-
creased risk for mortality in medical ICU [10]. In this work, to-
tal plasma protein level and serum albumin on admission were
signiﬁcantly lower in patients who received IMV when com-
pared with patients who received NIV and patients who re-
ceived conventional treatment only (Table 1). Utility of
prognostic value of serum albumin in patients with COPD is
interesting. Albumin has a long half-life of approximately
18 days and because of this fact it is unlikely to change with
development of acute respiratory failure in patients with
COPD. On the other hand serum albumin is known to reﬂect
the underlying nutritional status and to be affected by the
severity of chronic illness. These factors are of obvious signif-
icance in deciding the outcome of these patients [11].
In this study, all parameters of arterial blood gases (ABGs)
on admission were signiﬁcantly different among the three stud-
ied groups with the worst parameters in patients who received
IMV (Table 2).
In agreement with the results of this study Uegun et al.
(2006) [12] recorded that inadequate metabolic compensation
for respiratory acidosis was identiﬁed as an independent risk
factor for mortality in COPD patients with acute hypercapnic
respiratory failure being treated in the RICU.
In the current study serum potassium level on admission
was signiﬁcantly lower in patients who received IMV when
compared with patients who received NIV and patients who
received conventional treatment only (Table 2). The hypokale-
mia detected in this study could be due to treatment with ste-
roids, Beta 2 agonists and diuretics.
In the current work, NIV succeeded to avoid the necessity
for endotracheal intubation in 12 patients of group II (60%),
while it failed to improve 8 patients (40%) who needed IMV.
In group III, 48 patients (80%) were successfully weaned from
IMV, but 12 patients (20%) failed and died. The difference in
outcome between both patient groups (II & III) was statisti-
cally insigniﬁcant (Table 3).
The success rate of NIV obtained in this study is matched
with that reported by many other investigators Benhamou
et al. (1992) [13].
Other studies reported poorer outcome as regards the suc-
cess rate of NIV. Foglio et al. [14] had demonstrated no beneﬁt
of NIV in patients with AECOPD and reported that 49% oftheir patients failed to tolerate the mask, and patients who tol-
erated the mask were served as a control group.
Thus, although some contradictory results have been re-
ported, this study demonstrated that NIV could, in some situ-
ations, replace the invasive mechanical ventilation and reduce
the need for endotracheal intubation in this important group
of patients having acute respiratory failure due to COPD.
In the current study, the overall ICU mortality and read-
mission rates were signiﬁcantly highest in patients who re-
ceived IMV (mortality rate was 20% and readmission rate
was (63.3) (Table 4). While the overall discharge rate without
the need for readmission was 36% being signiﬁcantly highest
in patients who received conservative treatment only (70%).
The mortality rate with COPD exacerbation ranged
between 6% and 24% for those requiring ICU and it was
14–57% in patients requiring mechanical ventilation [15]. Re-
cently, the BODE index was shown to be better than FEV1
in predicting the risk of death among patients with COPD
[6]. This multifactorial scoring system that incorporates an
assessment of symptoms, nutritional state, and exercise capac-
ity together with the spirometric measure of airﬂow (FEV1)
can provide useful prognostic information in patients with
COPD. These parameters show statistical signiﬁcant difference
among the studied groups with the worst parameters in pa-
tients receiving invasive mechanical ventilation (Table 5). Con-
clusion: The overall ICU mortality and readmission rates were
highly found in patients who indicated IMV. On the other
hand the overall discharge rate without the need for readmis-
sion was noted to a great extent in patients who improved
on conservative treatment only.References
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